In this article, we will discuss Durvalumab (Indications-3). So, let’s get started.
- Biliary Tract Cancers
- Durvalumab, in combination with gemcitabine and cisplatin, is indicated for the treatment of adult patients with locally advanced or metastatic biliary tract cancer (BTC).